Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10

    • Polyethylenimine Linear (PEI, MW 40,000): Serum-Compatibl...

    2025-12-10

    Polyethylenimine Linear (PEI, MW 40,000): Serum-Compatible DNA Transfection Reagent for In Vitro Gene Expression

    Executive Summary. Polyethylenimine Linear (PEI, MW 40,000) is a synthetic, linear cationic polymer extensively applied as a DNA transfection reagent in vitro. It facilitates DNA condensation and endocytosis-mediated uptake in mammalian cells, achieving 60–80% transfection efficiency under optimal conditions [Li et al., 2025]. PEI-based protocols are compatible with serum-containing media and are routinely used for transient gene expression in HEK-293, CHO-K1, HepG2, and HeLa cells [APExBIO]. The reagent is scalable from 96-well plates to bioreactors up to 100 L. Its application supports recombinant protein production and gene function studies, as detailed in recent peer-reviewed and industry sources [internal].

    Biological Rationale

    Efficient gene delivery is essential for studying gene function, producing recombinant proteins, and modeling disease-relevant pathways. Linear polyethylenimine (PEI) with molecular weight 40,000 is positively charged, enabling it to bind and condense negatively charged DNA. This property is critical for mediating DNA uptake by mammalian cells in vitro [APExBIO]. The ability to use such transfection reagents in serum-containing media reduces cytotoxicity and supports cell viability, facilitating high-throughput and scalable applications [internal]. Polyethylenimine Linear is widely used in studies requiring transient gene expression, such as functional genomics and protein production workflows.

    Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

    PEI, MW 40,000, is a synthetic linear polymer with high density of amine groups. These primary and secondary amines impart a strong positive charge, which mediates electrostatic condensation of DNA molecules. The resulting PEI-DNA complexes (polyplexes) are nano-sized particles that efficiently interact with the negatively charged cell membrane proteoglycans and phospholipids [Li et al., 2025]. Uptake occurs primarily via endocytosis, after which the 'proton sponge' effect of PEI facilitates endosomal escape, releasing DNA into the cytoplasm for eventual nuclear import. The linear structure of PEI reduces cytotoxicity compared to branched forms and enhances reproducibility in transfection outcomes [internal].

    Evidence & Benchmarks

    Applications, Limits & Misconceptions

    Polyethylenimine Linear (PEI, MW 40,000) is employed for a range of applications including:

    • High-efficiency transient gene expression in mammalian cells (e.g., HEK-293, CHO-K1, HepG2, HeLa).
    • Recombinant protein production up to industrial (bioreactor) scale.
    • Gene function analysis and pathway screening in serum-compatible conditions.
    • Supports workflows from basic research to preclinical therapeutic candidate screening.

    This article extends the discussion in "Polyethylenimine Linear (PEI MW 40,000): Driving High-Eff..." by providing updated comparative benchmarks and clarifying the biological mechanisms underlying serum compatibility.

    Common Pitfalls or Misconceptions

    • PEI is not suitable for in vivo gene delivery due to toxicity and rapid clearance.
    • Excessive PEI or incorrect DNA:PEI ratios can increase cytotoxicity, reducing transfection efficiency.
    • PEI is ineffective for some primary or suspension cells without further optimization.
    • Repeated freeze-thaw cycles degrade PEI, leading to batch inconsistency; store at -20°C for long-term use and at 4°C for frequent use.
    • Not all commercial PEI preparations are equivalent; linear forms generally provide lower cytotoxicity and higher reproducibility than branched forms.

    Workflow Integration & Parameters

    Polyethylenimine Linear (PEI, MW 40,000) (SKU K1029) from APExBIO is supplied at 2.5 mg/mL in 4 mL and 8 mL vials [product page]. The recommended protocol involves mixing DNA with PEI at a 1:3 (w/w) ratio in a neutral buffer (pH 7.0–7.4), incubating for 15–20 minutes at room temperature, and applying directly to cells in serum-containing media. Transfection efficiency may be optimized by titrating DNA:PEI ratio and cell density specific to each cell line. The reagent's compatibility with high-density and suspension cultures supports scalability up to 100 liters, critical for industrial protein production workflows.

    This article clarifies and updates the protocol nuances presented in "Solving In Vitro Transfection Challenges with Polyethylen..." by specifying optimal storage and mixing parameters for reproducible results.

    For advanced insight into excipient-aided payload engineering and overcoming efficiency plateaus, see "Polyethylenimine Linear (PEI, MW 40,000): Next-Gen Strate..."; this article focuses instead on core reagent performance in standard workflows.

    Conclusion & Outlook

    Polyethylenimine Linear (PEI, MW 40,000) remains a leading DNA transfection reagent for in vitro gene expression, offering high efficiency, serum compatibility, and scalability. Its robust performance across diverse cell types, coupled with protocol flexibility, enables reproducible gene function studies and supports industrial-scale recombinant protein production. Ongoing research, such as the analysis of transcriptional regulation in neuroinflammation models, continues to refine best practices and expand the application landscape [Li et al., 2025]. For detailed protocols and procurement, refer to the official APExBIO product page.